Table of Contents Author Guidelines Submit a Manuscript
Behavioural Neurology
Volume 2017 (2017), Article ID 1470149, 7 pages
https://doi.org/10.1155/2017/1470149
Research Article

Prevalence of Anxiety among Hungarian Subjects with Parkinson’s Disease

1Department of Neurology, University of Pécs, Pécs, Hungary
2MTA-PTE Clinical Neuroimaging MR Research Group, Pécs, Hungary

Correspondence should be addressed to Norbert Kovács

Received 10 May 2017; Revised 27 July 2017; Accepted 3 August 2017; Published 26 September 2017

Academic Editor: Luigi Trojano

Copyright © 2017 Márton Kovács et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. P. Broen, N. E. Narayen, M. L. Kuijf, N. N. Dissanayaka, and A. F. Leentjens, “Prevalence of anxiety in Parkinson’s disease: a systematic review and meta-analysis,” Movement Disorders, vol. 31, no. 8, pp. 1125–1133, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. N. N. Dissanayaka, A. Sellbach, S. Matheson et al., “Anxiety disorders in Parkinson’s disease: prevalence and risk factors,” Movement Disorders, vol. 25, no. 7, pp. 838–845, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. N. N. Dissanayaka, J. D. O'Sullivan, N. A. Pachana et al., “Disease-specific anxiety symptomatology in Parkinson’s disease,” International Psychogeriatrics, vol. 28, no. 7, pp. 1153–1163, 2016. View at Publisher · View at Google Scholar · View at Scopus
  4. S. E. Starkstein, M. Dragovic, K. Dujardin et al., “Anxiety has specific syndromal profiles in Parkinson disease: a data-driven approach,” The American Journal of Geriatric Psychiatry, vol. 22, no. 12, pp. 1410–1417, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. F. J. Carod-Artal, S. Ziomkowski, H. Mourao Mesquita, and P. Martinez-Martin, “Anxiety and depression: main determinants of health-related quality of life in Brazilian patients with Parkinson’s disease,” Parkinsonism & Related Disorders, vol. 14, no. 2, pp. 102–108, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. N. N. Dissanayaka, E. Torbey, and N. A. Pachana, “Anxiety rating scales in Parkinson’s disease: a critical review updating recent literature,” International Psychogeriatrics, vol. 27, no. 11, pp. 1777–1784, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. A. F. Leentjens, K. Dujardin, G. M. Pontone, S. E. Starkstein, D. Weintraub, and P. Martinez-Martin, “The Parkinson Anxiety Scale (PAS): development and validation of a new anxiety scale,” Movement Disorders, vol. 29, no. 8, pp. 1035–1043, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Santangelo, F. Falco, A. D'Lorio et al., “Anxiety in early Parkinson’s disease: validation of the Italian observer-rated version of the Parkinson Anxiety Scale (OR-PAS),” Journal of the Neurological Sciences, vol. 367, pp. 158–161, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. C. L. Tomlinson, R. Stowe, S. Patel, C. Rick, R. Gray, and C. E. Clarke, “Systematic review of levodopa dose equivalency reporting in Parkinson’s disease,” Movement Disorders, vol. 25, no. 15, pp. 2649–2653, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. I. Litvan, K. P. Bhatia, D. J. Burn et al., “Movement Disorders Society Scientific Issues Committee report: SIC task force appraisal of clinical diagnostic criteria for Parkinsonian disorders,” Movement Disorders, vol. 18, no. 5, pp. 467–486, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders, American Psychiatric Publishing, Arlington, VA, 5th edition, 2013.
  12. K. Horvath, A. Zsuzsanna, P. Acs et al., “Validation of the Hungarian MDS-UPDRS: why do we need a new Parkinson scale?” Ideggyógyászati Szemle, vol. 67, no. 3-4, pp. 129–134, 2014. View at Google Scholar
  13. C. G. Goetz, B. C. Tilley, S. R. Shaftman et al., “Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results,” Movement Disorders, vol. 23, no. 15, pp. 2129–2170, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Horváth, Z. Aschermann, P. Ács et al., “Minimal clinically important difference on the motor examination part of MDS-UPDRS,” Parkinsonism & Related Disorders, vol. 21, no. 12, pp. 1421–1426, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Horváth, Z. Aschermann, M. Kovács et al., “Minimal clinically important differences for the experiences of daily living parts of Movement Disorder Society-sponsored Unified Parkinson’s Disease Rating Scale,” Movement Disorders, vol. 32, no. 5, pp. 789–793, 2017. View at Publisher · View at Google Scholar
  16. K. Horváth, Z. Aschermann, P. Acs et al., “Is the MDS-UPDRS a good screening tool for detecting sleep problems and daytime sleepiness in Parkinson’s disease?” Parkinsons Disease, vol. 2014, article 806169, 8 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. P. Martinez-Martin, C. Rodriguez-Blazquez, K. Abe et al., “International study on the psychometric attributes of the non-motor symptoms scale in Parkinson disease,” Neurology, vol. 73, no. 19, pp. 1584–1591, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Kovács, A. Makkos, Z. Aschermann et al., “Impact of sex on the nonmotor symptoms and the health-related quality of life in Parkinson’s disease,” Parkinsons Disease, vol. 2016, article 7951840, 12 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Deli, Z. Aschermann, P. Ács et al., “Bilateral subthalamic stimulation can improve sleep quality in Parkinson’s disease,” Journal of Parkinson's Disease, vol. 5, no. 2, pp. 361–368, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. A. F. Leentjens, K. Dujardin, L. Marsh, I. H. Richard, S. E. Starkstein, and P. Martinez-Martin, “Anxiety rating scales in Parkinson’s disease: a validation study of the Hamilton Anxiety Rating Scale, the Beck Anxiety Inventory, and the Hospital Anxiety and Depression Scale,” Movement Disorders, vol. 26, no. 3, pp. 407–415, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Weintraut, K. Karádi, T. Lucza et al., “Lille Apathy Rating Scale and MDS-UPDRS for screening apathy in Parkinson’s disease,” Journal of Parkinson’s Disease, vol. 6, no. 1, pp. 257–265, 2016. View at Publisher · View at Google Scholar · View at Scopus
  22. B. Kaszás, N. Kovács, I. Balás et al., “Sensitivity and specificity of Addenbrooke’s Cognitive Examination, Mattis Dementia Rating Scale, Frontal Assessment Battery and Mini Mental State Examination for diagnosing dementia in Parkinson’s disease,” Parkinsonism & Related Disorders, vol. 18, no. 5, pp. 553–556, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Lucza, K. Karádi, J. Kállai et al., “Screening mild and major neurocognitive disorders in Parkinson’s disease,” Behavioural Neurology, vol. 2015, Article ID 983606, 10 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Lucza, K. Karádi, S. Komoly et al., “Neurocognitive disorders in Parkinson’s disease,” Orvosi Hetilap, vol. 156, no. 23, pp. 915–926, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. N. Kovács, Z. Aschermann, P. Ács et al., “Levodopa/carbidopa intestinalis gél kezelés hatása az életminőségre [the impact of levodopa-carbidopa intestinal gel on health-related quality of life in Parkinson’s disease],” Ideggyógyászati Szemle, vol. 67, no. 7-8, pp. 245–250, 2014. View at Google Scholar
  26. K. Horváth, Z. Aschermann, M. Kovács et al., “Changes in quality of life in Parkinson’s disease: how large must they be to be relevant?” Neuroepidemiology, vol. 48, no. 1-2, pp. 1–8, 2017. View at Publisher · View at Google Scholar
  27. J. C. Hobart, A. Riazi, D. L. Lamping, R. Fitzpatrick, and A. J. Thompson, “Improving the evaluation of therapeutic interventions in multiple sclerosis: development of a patient-based measure of outcome,” Health Technology Assessment, vol. 8, no. 9, pp. 1–48, 2004, iii. View at Publisher · View at Google Scholar
  28. C. A. McHorney and A. R. Tarlov, “Individual-patient monitoring in clinical practice: are available health status surveys adequate?” Quality of Life Research, vol. 4, no. 4, pp. 293–307, 1995. View at Publisher · View at Google Scholar · View at Scopus
  29. R. D. Hays, R. Anderson, and D. Revicki, “Psychometric considerations in evaluating health-related quality of life measures,” Quality of Life Research, vol. 2, no. 6, pp. 441–449, 1993. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Nunnally and I. Bernstein, Psychometric Theory, McGraw-Hill, New York, 1994.
  31. N. Kovács, K. Horváth, Z. Aschermann et al., “Independent validation of Parkinson’s disease Sleep Scale 2nd version (PDSS-2),” Sleep and Biological Rhythms, vol. 14, no. 1, pp. 63–73, 2016. View at Publisher · View at Google Scholar · View at Scopus
  32. N. Aaronson, J. Alonso, A. Burnam et al., “Assessing health status and quality-of-life instruments: attributes and review criteria,” Quality of Life Research, vol. 11, no. 3, pp. 193–205, 2002. View at Google Scholar
  33. K. Horváth, Z. Aschermann, P. Acs et al., “Test-retest validity of Parkinson’s Disease Sleep Scale 2nd version (PDSS-2),” Journal of Parkinson's Disease, vol. 4, no. 4, pp. 687–691, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. P. Martinez-Martin, K. R. Chaudhuri, J. M. Rojo-Abuin et al., “Assessing the non-motor symptoms of Parkinson’s disease: MDS-UPDRS and NMS Scale,” European Journal of Neurology, 2013. View at Google Scholar
  35. J. Hobart, D. Lamping, R. Fitzpatrick, A. Riazi, and A. Thompson, “The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure,” Brain, vol. 124, Part 5, pp. 962–973, 2001. View at Publisher · View at Google Scholar
  36. N. N. Dissanayaka, R. A. Lawson, A. J. Yarnall et al., “Anxiety is associated with cognitive impairment in newly-diagnosed Parkinson’s disease,” Parkinsonism & Related Disorders, vol. 36, pp. 63–68, 2017. View at Publisher · View at Google Scholar
  37. M. P. Broen, S. Köhler, A. J. Moonen et al., “Modeling anxiety in Parkinson’s disease,” Movement Disorders, vol. 31, no. 3, pp. 310–316, 2016. View at Publisher · View at Google Scholar · View at Scopus